Motiva Breast Implants: SmoothSilk, Ergonomix & Innovation: Learn about Motiva breast implants, SmoothSilk technology, Ergonomix design, FDA status, warranty, safety data, and comparisons. Includes key tips.
Key Takeaways
- Motiva (by Establishment Labs) received FDA approval in 2024, making it the newest breast implant brand in the US market.
- SmoothSilk/SilkSurface is Motiva's proprietary nano-textured surface — designed to reduce capsular contracture risk while maintaining a low BIA-ALCL profile.
- Ergonomix2 is Motiva's flagship implant, featuring Progressive Gel that adapts shape with body position (more natural movement).
- TrueMonobloc shell construction uses a single piece of silicone (no patch joints) for enhanced shell integrity.
- Motiva has been used in 80+ countries since 2010, with extensive international data, but US-specific long-term data is still building.
- The Q Inside Safety Technology allows post-surgical implant identification via RFID micro-transponder.
Company Overview
Motiva is manufactured by Establishment Labs, a Costa Rica-based medical device company founded in 2004. Motiva implants have been commercially available in Europe, Latin America, and Asia since 2010, with FDA approval for the US market granted in September 2024.
Motiva positions itself as the innovation leader in breast implant technology, introducing several novel features not found in competing products.
Key Technologies
Motiva differentiates through several proprietary technologies:
SmoothSilk / SilkSurface
Motiva's signature surface technology uses a nano-textured surface created directly during the manufacturing process (not by foam imprinting or salt-loss techniques). The surface has a controlled average roughness of ~4 micrometers — much finer than traditional textured surfaces.
The design rationale: provide enough surface irregularity to encourage organized tissue adherence and reduce capsular contracture, while being smooth enough to minimize the chronic inflammation associated with macro-textured surfaces and BIA-ALCL.
Progressive Gel
Motiva's gel fill responds to body position and gravity, creating more natural breast movement. When upright, the gel settles toward the lower pole (mimicking natural breast shape). When supine, it distributes more evenly. This is in contrast to form-stable (gummy bear) implants that maintain the same shape regardless of position.
TrueMonobloc Shell
Traditional breast implant shells are made from two pieces joined together with a patch (at the base). Motiva's TrueMonobloc uses a single continuous piece of silicone for the entire shell — eliminating the patch joint, which is traditionally the weakest point of the shell and the most common rupture site.
Q Inside Safety Technology
An embedded RFID micro-transponder that allows non-invasive identification of the implant after surgery. Using a handheld scanner, surgeons can verify the implant model, serial number, and size without imaging or surgery. This is particularly useful for patients who don't have their implant cards or records.
BluSeal Visual Indicator
A barrier layer inside the shell that changes the visual appearance of the implant surface if the outer shell is compromised — acting as a visual indicator of shell integrity during surgery or revision.
Product Lines
Motiva's current US portfolio:
Ergonomix2
Motiva's flagship implant, featuring Progressive Gel and SmoothSilk surface:
- Shape: Round design that behaves like an anatomical implant due to Progressive Gel response to gravity.
- Surface: SmoothSilk nano-texture.
- Gel: Progressive Gel for natural movement and position-responsive shape.
- Shell: TrueMonobloc construction.
- Profiles: Mini, Demi, Full, and Corsé — corresponding to low through high projection.
Motiva Round
Traditional round silicone gel implants with SmoothSilk surface for patients or surgeons who prefer standard gel cohesivity.
FDA Approval & Available Data
Motiva received FDA PMA (Premarket Approval) in September 2024, based on:
- Clinical trial data from US patients enrolled in the pivotal study.
- Extensive international post-market surveillance data from 80+ countries.
- More than 3 million Motiva devices implanted worldwide (as of 2024).
While Motiva has extensive international data, US-specific long-term data (5–10 years) is still being collected through FDA-required post-approval studies. This is not unusual for a newly approved device but means less US-specific evidence compared to Allergan or Mentor, which have 15+ years of US data.
Warranty: Motiva Warranty Program
Motiva offers warranty coverage for qualifying complications:
Motiva warranty overview. Verify current terms with your surgeon as programs may be updated.
| Benefit | Coverage Period | Details |
|---|---|---|
| Implant replacement (rupture) | Lifetime | Free replacement implant pair |
| Financial assistance | 10 years | Financial assistance for covered surgical costs |
| Capsular contracture | 10 years | Coverage for Baker III/IV contracture |
| Registration | Required | Must be registered through the surgeon/clinic |
How Motiva Compares
In the competitive landscape:
- vs. Allergan/Mentor: Motiva brings genuinely novel technology (Progressive Gel, TrueMonobloc, SmoothSilk) but lacks the 10+ years of US-specific data that Allergan and Mentor have. For patients who prioritize innovation, Motiva is compelling. For those who prioritize extensive long-term data, Allergan or Mentor may be preferred.
- vs. Sientra: Both are newer brands. Motiva offers more technological innovation; Sientra offers the surgeon-only model and industry-leading warranty.
- Surface technology: SmoothSilk sits between smooth and traditional textured surfaces — potentially offering benefits of both without the BIA-ALCL risk of macro-texturing.
- International data: Motiva's global dataset (3M+ implants) is the largest of any brand, even if US-specific data is newer.
Frequently Asked Questions
References & Sources
- Motiva Implants Important Safety Information. Motiva Product Information (2025) . View source ↗
- Preliminary 3-year evaluation of experience with SilkSurface and VelvetSurface Motiva silicone breast implants. Plastic and Reconstructive Surgery (2019) . View source ↗
- FDA Approves Motiva Implants for Breast Augmentation and Reconstruction. FDA News Release (2024) . View source ↗
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with a board-certified plastic surgeon or qualified healthcare provider before making any medical decisions.